The New York Stock Exchange recently announced that NYSE Texas has reached a milestone of 100 dual listings, representing ...

Abstract: The increasing number of vehicles-related incidents demands a more efficient and accurate method to detect and identify vehicle license plates. In answering this challenge, a prototype of a ...

TAIPEI, TW, Jan 12, 2026 - (ACN Newswire) - OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based ...

Summit Therapeutics Inc. ("Summit," "we," or the "Company") today announced that it has submitted a Biologics License ...

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss ...

Agency leaders share how emotion shapes trust, loyalty and long-term impact, revealing why the way brands make people feel ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – Genomics-driven cancer diagnostics are ...

Digital Art and Design Tools Market size is expected to be worth around USD 76 bn by 2034, from USD 15 bn in 2024, growing at ...

This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...

FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment SHANGHAI and ATLANTA and NEW HAVEN, Conn., Jan. 05, 2026 (GLOBE ...

Source-available Kubernetes ingress controller designed as a modern replacement for Ingress NGINX, supporting over 50 NGINX annotations for compatibility. MCLEAN, VA, UNITED STATES, January 4, 2026 ...

Outlook Therapeutics faces a pivotal FDA decision for Lytenava on December 31st, following two prior rejections. Read why ...